Top Insider Trades: WBMD OPK AYR AMED

By Jonathan Moreland, founder of Insider Insights and author of Profit From Legal Insider Trading.

NEW YORK ( TheStreet) -- It is a victory for common sense. Tracking the trading behavior of company executives, directors and large shareholders in the stocks of firms they're registered in as "insiders" has proven to be profitable, according to both academic studies and (more importantly) the experience of professional investors.

Below are lists of the top 10 mainly open-market insider purchases and sales filed at the Securities and Exchange Commission Monday, Oct 21, 2013, as ranked by dollar value. Please note, however, that these are only factual lists, not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.

At, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

So use these regular Top Insider Trades columns as the initial research tools they are meant to be, and click the links in the tables to analyze a company's or insider's full insider history. Also feel free to contact us with any questions on our proprietary insider data, and how it is best analyzed.
Marubeni DIR,BO 30,000 543,378
Opko Health (OPK) Frost Phillip Md CEO,CB,BO 22,700 269,568
Amedisys (AMED) Kkr Asset Mgt BO 12,652 227,053
Global Pmnts (GPN) Wilkins Gerald J DIR 2,500 141,871
Neonode (NEON) Lindqvist Lars G DIR 15,000 93,824
Del Friscos Rest (DFRG) Mednansky Mark CEO,DIR 5,000 91,750
Cat Pharma (CPRX) McEnany Patrick J PR,CEO,DIR 50,000 79,730
Angiodynamics (ANGO) Bucci Vincent DIR 5,000 75,990
Stratus Prop (STRS) Madden Michael D DIR 5,000 66,300
Stratus Prop (STRS) Lenehan William H DIR 5,000 66,300
Source: Insider Insights
Webmd (WBMD) Icahn Carl C SEC 5,527,433 177,320,048
Gehring Fred CEO,DIR 81,799 9,933,277
Kellogg (K) Kellogg WK Fdn BO 125,996 7,685,756
Atlas Fncl (AFH) Kingsway America BO 529,608 5,536,600
D Emmett (DEI) Emmett Dan A CB,DIR 140,000 3,529,652
Dolby Labs (DLB) Dolby Dagmar BO 70,000 2,456,574
Mnstr Bev (MNST) Sacks Rodney C CB,CEO,DIR 35,000 2,043,300
Mnstr Bev (MNST) Schlosberg Hilton VCB,PR,DIR 35,000 2,041,900
Onnink Ludovicus COO 16,487 2,002,101
Sheedy William M O 8,500 1,681,385
Source: Insider Insights

Key to Titles: A=Assistant, AI=Affiliated Investor, AO=Accounting Officer, BD=Business Development, BO=Beneficial Owner, CAO=Chief Accounting Officer, CB=Chairman, CCO=Chief Compliance Officer, CEO=Chief Executive Officer, CFO=Chief Financial Officer, CIO=Chief Information Officer, CO=Compliance Officer, COO=Chief Operating Officer, CT=Controller, CTO=Chief Technology Officer, DIR=Director, EVP=Executive Vice President, F=Founder, FO=Financial Officer, GC=General Counsel, HR=Human Resources, IO=Information Officer, IR=Investor Relations, LO=Legal Officer, MD=Managing Director, O=Officer, OO=Operating Officer, PR=President, PT=Partner, REL=Relative of an insider, SEC=Secretary, SH=Shareholder, SO=Sales Officer, TO=Technology Officer, TR=Treasurer, TT=Trustee, VCB=Vice Chairman, VP=Vice President, X=Ex Officer or other title displayed.
Jonathan Moreland is the founder of, which produces a weekly newsletter and offers professional screening and alerting tools to analyze a proprietary, real-time insider data feed. He is also the principal of Insider Asset Management, a registered investment advisor in New York. Mr. Moreland has been analyzing insider data professionally for two decades and has been a contributor to since 2001. A fundamental analyst with an MBA in finance, Mr. Moreland long ago identified insider data as an excellent first screen to determine where to focus his research efforts. He is quoted frequently in the media for his insider analysis and stock recommendations stemming from it. He is also author of Profit From Legal Insider Trading.

Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. While he cannot provide investment advice or recommendations, Moreland appreciates your feedback; click here to send him an email.

If you liked this article you might like

Private Briefing: KKR's Healthcare Deal Spree

KKR's WebMD Acquisition Is a Big Win for an Activist Investor